Immunogenic compositions for use in pneumococcal vaccines
US11135279B2 · kind B2 · utility
2Cited by
13References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 9, 2020 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Apr 9, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 9, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.